Krystal Biotech SG&A Expense (TTM) Analysis

Krystal Biotech Inc (KRYS)

177.61 -4.66 (-2.56%) USD | NASDAQ | Jul 02, 16:00

177.64 +0.03 (+0.02%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	100.42M
December 31, 2023	98.40M
September 30, 2023	97.67M
June 30, 2023	93.90M
March 31, 2023	85.86M
December 31, 2022	77.74M
September 30, 2022	66.57M
June 30, 2022	56.21M
March 31, 2022	48.15M
December 31, 2021	40.39M
September 30, 2021	32.27M
June 30, 2021	27.28M
March 31, 2021	20.80M
December 31, 2020	15.06M

Date	Value
September 30, 2020	12.12M
June 30, 2020	8.998M
March 31, 2020	7.357M
December 31, 2019	6.463M
September 30, 2019	6.075M
June 30, 2019	5.676M
March 31, 2019	4.926M
December 31, 2018	4.156M
September 30, 2018	3.149M
June 30, 2018	2.829M
March 31, 2018	2.174M
December 31, 2017	1.563M
September 30, 2017	1.371M
June 30, 2017	0.714M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.075M

Minimum

Sep 2019

100.42M

Maximum

Mar 2024

47.46M

Average

40.39M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks